FDA — authorised 1 April 1968
- Application: NDA016267
- Marketing authorisation holder: MITEM PHARMA
- Status: supplemented
FDA authorised Desferal on 1 April 1968
Yes. FDA authorised it on 1 April 1968; FDA has authorised it.
MITEM PHARMA holds the US marketing authorisation.